Both in Pharmaceuticals
Cue Biopharma vs Spruce Biosciences
Over the past year CUE returned −3.0% and SPRB returned −55.7%; their daily moves had a correlation of 0.07.
CUE −3.0% SPRB −55.7%Growth of $1, one year, split-adjusted
| Metric | CUE | SPRB |
|---|---|---|
| Price | $20.87 | $46.39 |
| Market cap | $151.6M | $133.3M |
| Today | −2.70% | −0.92% |
| 1 month | −17.3% | +3.6% |
| 6 months | −31.4% | −19.0% |
| Year to date | +127.8% | −46.7% |
| 1 year | +0.8% | −60.7% |
| Revenue growth (YoY) | +166.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −1943.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 4.0× | — |
| Net cash | $16.4M | $89.2M |
| Dividend yield | — | — |
| Volatility (60d) | 137.1% | 63.5% |
| Short % of float | 12.2% | 22.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).